S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.02 (-1.75%)
AAPL   165.59 (-0.87%)
MSFT   400.44 (-0.95%)
META   482.20 (-3.91%)
GOOGL   154.01 (-1.28%)
AMZN   174.84 (-2.44%)
TSLA   148.37 (-1.04%)
NVDA   786.21 (-7.15%)
AMD   147.95 (-4.60%)
NIO   3.82 (-4.50%)
BABA   68.93 (+0.07%)
T   16.44 (+0.67%)
F   12.11 (+0.41%)
MU   107.04 (-4.37%)
GE   148.62 (-2.82%)
CGC   8.00 (+2.17%)
DIS   112.29 (-0.12%)
AMC   3.21 (+9.93%)
PFE   25.85 (+1.81%)
PYPL   62.10 (+0.00%)
XOM   119.76 (+1.05%)
S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.02 (-1.75%)
AAPL   165.59 (-0.87%)
MSFT   400.44 (-0.95%)
META   482.20 (-3.91%)
GOOGL   154.01 (-1.28%)
AMZN   174.84 (-2.44%)
TSLA   148.37 (-1.04%)
NVDA   786.21 (-7.15%)
AMD   147.95 (-4.60%)
NIO   3.82 (-4.50%)
BABA   68.93 (+0.07%)
T   16.44 (+0.67%)
F   12.11 (+0.41%)
MU   107.04 (-4.37%)
GE   148.62 (-2.82%)
CGC   8.00 (+2.17%)
DIS   112.29 (-0.12%)
AMC   3.21 (+9.93%)
PFE   25.85 (+1.81%)
PYPL   62.10 (+0.00%)
XOM   119.76 (+1.05%)
S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.02 (-1.75%)
AAPL   165.59 (-0.87%)
MSFT   400.44 (-0.95%)
META   482.20 (-3.91%)
GOOGL   154.01 (-1.28%)
AMZN   174.84 (-2.44%)
TSLA   148.37 (-1.04%)
NVDA   786.21 (-7.15%)
AMD   147.95 (-4.60%)
NIO   3.82 (-4.50%)
BABA   68.93 (+0.07%)
T   16.44 (+0.67%)
F   12.11 (+0.41%)
MU   107.04 (-4.37%)
GE   148.62 (-2.82%)
CGC   8.00 (+2.17%)
DIS   112.29 (-0.12%)
AMC   3.21 (+9.93%)
PFE   25.85 (+1.81%)
PYPL   62.10 (+0.00%)
XOM   119.76 (+1.05%)
S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.02 (-1.75%)
AAPL   165.59 (-0.87%)
MSFT   400.44 (-0.95%)
META   482.20 (-3.91%)
GOOGL   154.01 (-1.28%)
AMZN   174.84 (-2.44%)
TSLA   148.37 (-1.04%)
NVDA   786.21 (-7.15%)
AMD   147.95 (-4.60%)
NIO   3.82 (-4.50%)
BABA   68.93 (+0.07%)
T   16.44 (+0.67%)
F   12.11 (+0.41%)
MU   107.04 (-4.37%)
GE   148.62 (-2.82%)
CGC   8.00 (+2.17%)
DIS   112.29 (-0.12%)
AMC   3.21 (+9.93%)
PFE   25.85 (+1.81%)
PYPL   62.10 (+0.00%)
XOM   119.76 (+1.05%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
$56.97
+0.9%
$67.38
$42.83
$75.73
$4.24B1.351.34 million shs821,262 shs
Genpact Limited stock logo
G
Genpact
$31.44
+1.8%
$33.69
$29.41
$44.96
$5.67B1.071.51 million shs513,116 shs
23andMe Holding Co. stock logo
ME
23andMe
$0.49
-2.5%
$0.54
$0.35
$2.21
$237.94M1.277.34 million shs13.97 million shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
-2.03%-5.27%-20.53%-10.24%-16.51%
Genpact Limited stock logo
G
Genpact
+1.10%-2.74%-8.42%-12.64%-31.26%
23andMe Holding Co. stock logo
ME
23andMe
+41.91%+9.51%+7.32%-28.86%-75.70%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
4.6566 of 5 stars
4.44.01.70.02.90.03.8
Genpact Limited stock logo
G
Genpact
3.8889 of 5 stars
3.03.03.30.01.92.52.5
23andMe Holding Co. stock logo
ME
23andMe
0.2236 of 5 stars
1.01.00.00.02.32.50.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
2.85
Moderate Buy$74.0029.89% Upside
Genpact Limited stock logo
G
Genpact
2.00
Hold$40.1127.58% Upside
23andMe Holding Co. stock logo
ME
23andMe
2.00
Hold$0.47-4.61% Downside

Current Analyst Ratings

Latest G, ME, and ASO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/16/2024
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$75.00 ➝ $70.00
4/16/2024
23andMe Holding Co. stock logo
ME
23andMe
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$0.85 ➝ $0.47
4/12/2024
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$85.00
4/1/2024
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$80.00
3/25/2024
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$65.00 ➝ $72.00
3/22/2024
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$70.00 ➝ $80.00
3/22/2024
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$88.00 ➝ $83.00
3/22/2024
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$75.00 ➝ $78.00
3/22/2024
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$70.00 ➝ $65.00
3/22/2024
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$80.00
3/22/2024
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$86.00 ➝ $82.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
$6.16B0.69$8.45 per share6.74$26.36 per share2.16
Genpact Limited stock logo
G
Genpact
$4.48B1.27$3.22 per share9.77$12.40 per share2.54
23andMe Holding Co. stock logo
ME
23andMe
$299.49M0.79N/AN/A$1.55 per share0.32

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
$519.19M$6.728.487.630.848.43%28.99%10.98%6/4/2024 (Estimated)
Genpact Limited stock logo
G
Genpact
$631.26M$3.439.1710.691.4314.10%23.19%10.23%5/9/2024 (Confirmed)
23andMe Holding Co. stock logo
ME
23andMe
-$311.66M-$1.11N/AN/A-210.48%-52.99%-39.32%5/23/2024 (Estimated)

Latest G, ME, and ASO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Genpact Limited stock logo
G
Genpact
$0.62N/A-$0.62N/AN/AN/A  
2/8/2024Q4 2023
Genpact Limited stock logo
G
Genpact
$0.65$0.68+$0.03-$0.23$1.12 billion$1.15 billion
2/7/2024Q3 2024
23andMe Holding Co. stock logo
ME
23andMe
N/A-$0.17-$0.17$0.24$56.30 million$44.75 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
$0.440.77%N/A6.55%2 Years
Genpact Limited stock logo
G
Genpact
$0.611.94%+12.14%17.78%7 Years
23andMe Holding Co. stock logo
ME
23andMe
N/AN/AN/AN/AN/A

Latest G, ME, and ASO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/7/2024
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
Quarterly$0.110.63%3/25/20243/26/20244/18/2024
2/8/2024
Genpact Limited stock logo
G
Genpact
Quarterly$0.15301.68%3/8/20243/11/20243/26/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
0.25
1.87
0.51
Genpact Limited stock logo
G
Genpact
0.37
1.44
1.44
23andMe Holding Co. stock logo
ME
23andMe
N/A
2.15
2.04

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
N/A
Genpact Limited stock logo
G
Genpact
96.03%
23andMe Holding Co. stock logo
ME
23andMe
36.10%

Insider Ownership

CompanyInsider Ownership
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
3.56%
Genpact Limited stock logo
G
Genpact
2.80%
23andMe Holding Co. stock logo
ME
23andMe
27.55%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Academy Sports and Outdoors, Inc. stock logo
ASO
Academy Sports and Outdoors
22,00074.40 million71.76 millionNot Optionable
Genpact Limited stock logo
G
Genpact
129,100180.33 million175.28 millionOptionable
23andMe Holding Co. stock logo
ME
23andMe
769482.92 million349.87 millionNot Optionable

G, ME, and ASO Headlines

SourceHeadline
23andMe CEO Proposes to Take Company Private After Shares Plunge to Over 95%23andMe CEO Proposes to Take Company Private After Shares Plunge to Over 95%
techtimes.com - April 19 at 9:46 AM
Once Valued At Billions, 23andMes CEO Considers Privatization To Secure Companys FutureOnce Valued At Billions, 23andMe's CEO Considers Privatization To Secure Company's Future
msn.com - April 19 at 9:46 AM
23andMe wants to go private. It’s the latest in a line of failed SPACs23andMe wants to go private. It’s the latest in a line of failed SPACs
fastcompany.com - April 19 at 9:46 AM
Column: Law firm Edelson pitches radical idea for picking lead in 23andMe case. Ask class members.Column: Law firm Edelson pitches radical idea for picking lead in 23andMe case. Ask class members.
reuters.com - April 18 at 7:20 PM
23andMe going private23andMe going private
bizjournals.com - April 18 at 1:27 PM
23andMes business is basically worthless. Its CEO now wants to buy it.23andMe's business is basically worthless. Its CEO now wants to buy it.
msn.com - April 18 at 1:27 PM
23andMe CEO reveals take-private plan23andMe CEO reveals take-private plan
proactiveinvestors.com - April 18 at 11:51 AM
ME Stock Alert: CEO Anne Wojcicki Seeks to Save 23andMe in Take-Private DealME Stock Alert: CEO Anne Wojcicki Seeks to Save 23andMe in Take-Private Deal
investorplace.com - April 18 at 10:44 AM
23andMe CEO Wojcicki Plans To Take DNA-Testing Firm Private23andMe CEO Wojcicki Plans To Take DNA-Testing Firm Private
investopedia.com - April 18 at 10:30 AM
23andMe CEO Anne Wojcicki considers taking company private23andMe CEO Anne Wojcicki considers taking company private
cnbc.com - April 18 at 10:07 AM
23andme CEO Anne Wojcicki moves to take company private23andme CEO Anne Wojcicki moves to take company private
statnews.com - April 18 at 8:27 AM
Wall Street Breakfast Podcast: TikTok Divestment Bill On Potential Fast TrackWall Street Breakfast Podcast: TikTok Divestment Bill On Potential Fast Track
seekingalpha.com - April 18 at 8:27 AM
23andMe Holding (ME) Price Target Decreased by 13.33% to 1.2623andMe Holding (ME) Price Target Decreased by 13.33% to 1.26
msn.com - April 18 at 8:27 AM
23andMe CEO Anne Wojcicki eyes taking DNA-testing company private23andMe CEO Anne Wojcicki eyes taking DNA-testing company private
msn.com - April 18 at 8:27 AM
23andMe announces CEO’s intention to pursue a potential take-private23andMe announces CEO’s intention to pursue a potential take-private
finance.yahoo.com - April 18 at 8:27 AM
23andMe announces CEOs intention to pursue a potential take-private23andMe announces CEO's intention to pursue a potential take-private
globenewswire.com - April 18 at 8:00 AM
23andMe May Disappear as Public Stock23andMe May Disappear as Public Stock
247wallst.com - April 18 at 6:35 AM
23andMe CEO Anne Wojcicki Plans to Take Company Private23andMe CEO Anne Wojcicki Plans to Take Company Private
msn.com - April 18 at 1:20 AM
23andMe CEO Wojcicki considering taking firm private, filing shows23andMe CEO Wojcicki considering taking firm private, filing shows
reuters.com - April 17 at 11:13 PM
Can 23andMe Holding (NASDAQ:ME) Afford To Invest In Growth?Can 23andMe Holding (NASDAQ:ME) Afford To Invest In Growth?
finance.yahoo.com - April 17 at 2:36 PM
23andMe (NASDAQ:ME) Price Target Cut to $0.47 by Analysts at Citigroup23andMe (NASDAQ:ME) Price Target Cut to $0.47 by Analysts at Citigroup
americanbankingnews.com - April 17 at 4:46 AM
Is Walton Goggins a Descendant Of Irish Royalty? Fallout Star RevealsIs Walton Goggins a Descendant Of Irish Royalty? Fallout Star Reveals
pinkvilla.com - April 16 at 12:34 PM
23andMe shrinks its South San Francisco headquarters footprint23andMe shrinks its South San Francisco headquarters footprint
bizjournals.com - April 15 at 9:25 PM
How a DNA test solved the biggest mystery in one mans lifeHow a DNA test solved the biggest mystery in one man's life
ctvnews.ca - April 15 at 9:20 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Academy Sports and Outdoors logo

Academy Sports and Outdoors

NASDAQ:ASO
Academy Sports and Outdoors, Inc., through its subsidiaries, operates as a sporting goods and outdoor recreational retailer in the United States. The company outdoor division comprises camping products, such as coolers and drinkware, and camping accessories and equipment,; fishing products, including marine equipment and fishing rods, reels, and baits and equipment; and hunting products, which includes firearms, ammunition, archery and archery equipment, camouflage apparel, waders, shooting accessories, gun safes, optics, airguns, and hunting equipment. Its sports and recreation division offers fitness equipment, fitness accessories, and nutrition supplies; team and specialty sports equipment, including baseball, football, basketball, soccer, golf, racket sports, volleyball, backpacks, and sports bags; recreation products, which includes patio furniture, outdoor cooking, trampolines, play sets, watersports, and pet equipment, as well as wheeled goods including bicycles, skateboards, and other ride-on toys; and electronics and watches, as well as front-end products, such as consumables, batteries, etc. The company's apparel division provides outdoor and seasonal apparel, denim, work apparel, graphic t-shirts, and accessories; boys and girls outdoor, and athletic apparel; sporting and fitness apparel; and professional and collegiate team licensed apparel and accessories. Its footwear division offers casual shoes, slippers, seasonal footwear, and socks; work and western boots, shoes, and hunting footwear; boys and girls footwear; athletic footwear, such as running shoes, athletic lifestyle, and training shoes; and team and specialty sports footwear, and slides. The company sells its products under the Academy Sports + Outdoors, Magellan Outdoors, BCG, O'rageous, Game Winner, Outdoor Gourmet, and Freely brand names. Academy Sports and Outdoors, Inc. was founded in 1938 and is headquartered in Katy, Texas.
Genpact logo

Genpact

NYSE:G
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims. The Consumer and Healthcare segment provides demand generation, sensing and planning, supply chain planning and management, pricing and trade promotion management, deduction recovery management, order management, and digital commerce; and end-to-end claim lifecycle management, from claims processing and adjudication to claims recovery and payment integrity, revenue cycle management, health equity analytics, and care services. The High Tech and Manufacturing segment offers industry-specific solutions for trust and safety, advertising sales support, customer and user experience, and customer care support; and direct and indirect procurement, logistics, field, aftermarket support, and engineering services. It also provides digital operation services; data-tech-Al services; finance and accounting services, such as accounts payable, invoice-to-cash, record to report, financial planning and analysis, and enterprise risk and compliance; CFO advisory services; supply chain, and sourcing and procurement services; sales and commercial, and marketing and experience services; and environmental, social and governance services. The company was founded in 1997 and is based in Hamilton, Bermuda.
23andMe logo

23andMe

NASDAQ:ME
23andMe Holding Co. operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. This segments also operates Lemonaid telehealth platform to access affiliated licensed healthcare professionals for medical consultation and treatment for various common conditions; and offers research services. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to enhance patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing intellectual property associated with identified drug targets related to drug candidates under clinical development. The company's therapeutics product portfolio comprises 23ME-00610 (P006), a humanized monoclonal antibody, which is in phase 1/2a clinical trials to interfere with the ability of CD200R1 to interact with CD200 in cancer cells; and GSK6097608, an antibody that targets CD96 for attenuating T and NK cell anti-tumor immune responses. The company was incorporated in 2006 and is headquartered in South San Francisco, California.